Devices for closing wound

Abstract

To provide devices for closing a wound, such as a tissue defect resulting from an endoscopic mucosal resection or endoscopic submucosal dissection procedure.SOLUTION: A device for closing a wound includes a closure element 100 having a delivery configuration and a deployed configuration, the closure element configured to be disposed about an endcap 120 of an endoscope in the delivery configuration. A release filament 102 may have a distal end 102d releasably coupled to the closure element, and a proximal end extending within the endcap. The closure element may be configured to substantially close about the wound in the deployed configuration.SELECTED DRAWING: Figure 1B

Description

[Technical field]

[0001] The present invention relates to medical devices, and more particularly to devices, systems, and methods for closing tissue, such as tissue defects or wounds resulting from endoscopic procedures, such as mucosal resection or endoscopic submucosal dissection procedures. [Background technology]

[0002] Wounds in tissue or openings or defects, such as tissue defects in body lumens resulting from Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD), can become so large that they are less likely to close naturally or take longer to close. The longer a wound remains open, the greater the risk of infection. Wounds that are larger than the direct working area of ​​the endoscope can also be difficult to close using devices sized to extend through the working channel of the endoscope.

[0003] With the above considerations in mind, the improvements of the present disclosure would be useful. Summary of the Invention

[0004] The present invention, in its various aspects, is directed to medical devices, and more particularly, devices, systems, and methods for closing a wound. In one aspect, a device for closing a wound includes a closure element that may have a delivery configuration and a deployed configuration. The closure element is configured to be disposed about an end cap of an endoscope in the delivery configuration. A detachment filament has a distal end that is releasably coupled to the closure element and a proximal end that may extend within the end cap. The closure element is configured to substantially close about the wound in the deployed configuration.

[0005] In various embodiments described herein or otherwise, the multiple closure elements may each be separately and releasably coupled to the detachment filament in a delivery configuration around the end of the endoscope. The deployed configuration of the closure elements may be a shape memory configuration. The shape memory configuration of the closure elements may be a coil, a knot, or a torus, or a combination thereof. The closure elements may extend along a length between ends. The closure elements may further include tissue penetrating protrusions at each end of the closure elements. The tissue penetrating protrusions may be hooks, tines, or barbs, or a combination thereof. The shape memory configuration of the closure elements may be activated by a stimulus. The stimulus may be light activation, heat activation, or electrical activation, or a combination thereof. The distal end of the detachment filament may include a loop. The detachment filament may have a tensile strength greater than a tensile strength of the closure element. The loop may be disposed around the coil of the closure element. The loop may be disposed around the length of the closure element.

[0006] In one aspect, a device for closing a wound can include a closure element having an elongate, unactivated configuration and an activated configuration. The closure element in the elongate, unactivated configuration can be configured to be inserted into tissue edges opposing the wound. The closure element in the activated configuration can be configured to approximate the tissue edges to substantially close at least a portion of the wound.

[0007] In various embodiments described herein or otherwise, the closure element may include a plurality of biodegradable portions interspersed between a plurality of adjacent light-activated shape memory portions along the length of the closure element. The closure element may include first and second ends configured to curl toward each other in the activated configuration. The activated configuration of the closure element may be a light-activated shape memory configuration. The closure element includes a plurality of biodegradable portions interspersed between a plurality of adjacent light-activated shape memory portions along the length of the closure element.

[0008] In one aspect, a method for closing a wound may include inserting a catheter into a patient's body. A distal end of the catheter may be oriented to the wound. Suction may be applied to the wound such that the wound is at least partially displaced within the catheter. A self-retracting closure element may be deployed from around the catheter and into the at least partially displaced wound within the catheter. Deploying the closure element may include actuating a detachment filament coupled to the closure element. Additional closure elements may be deployed from around the catheter each separately and releasably coupled to the detachment filament in the delivery configuration. Actuating the detachment filament may include moving the detachment filament proximally to deploy the closure element. The detachment filament may be moved in a proximal direction at least until the detachment filament separates from the closure element. The catheter may be an endoscope. The closure element may be loaded around a cap attached to a distal end of the endoscope. The detachment filament may be backloaded through a working channel to a proximal end of the endoscope. The closure element may be removed from the patient's body after the wound is substantially healed. The self-contracting closure element may be energy activated after the closure element is deployed. The shape of the closure element may be a helix.

[0009] Non-limiting examples of the present disclosure are described by way of example with reference to the accompanying figures, which are schematic and are not intended to be drawn to scale, in which each of the identical or nearly identical components shown are generally represented by a single numeral. For clarity, not every component is labeled in every figure, and not every component of each embodiment of the present disclosure is shown unless illustration is necessary to enable those skilled in the art to understand the disclosure. [Brief description of the drawings]

[0010] [Figure 1A] 1 illustrates an endoscope with a cap having a closure element oriented towards a wound, according to an embodiment of the present invention. [Figure 1B]FIG. 1B illustrates the endoscope of FIG. 1A with the wound at least partially displaced within the cap of the endoscope. [Figure 1C] FIG. 1C illustrates the closure element of FIGS. 1A and 1B deployed around a wound. [Figure 1D] FIG. 1D shows the closure element of FIGS. 1A-1C deployed around a wound. [Figure 2A] 1 illustrates an endoscope having a closure element oriented towards a wound, according to one embodiment of the present invention. [Figure 2B] FIG. 2B illustrates the closure element of FIG. 2A in a deployed configuration. [Figure 2C] 2B is a view showing the endoscope of FIG. 2A displacing the wound and the closure elements of FIGS. 2A and 2B being deployed around the wound. [Figure 2D] 2A-2C are shown deployed around a wound. [Figure 2E] FIG. 2E shows the closure element of FIGS. 2A-2D in a delivery configuration. [Figure 3A] 1 illustrates an end cap having multiple closure elements, according to one embodiment of the present invention. [Figure 3B] FIG. 3B illustrates the end cap of FIG. 3A deploying a closure element. [Figure 4A] FIG. 13 illustrates a closure element in a non-activated delivery configuration, according to an embodiment of the present invention. [Figure 4B] FIG. 4B illustrates the closure element of FIG. 4A in an activated configuration. [Figure 4C] FIG. 4C shows the closure element of FIGS. 4A and 4B oriented at a wound. [Figure 4D] FIG. 4D shows the closure element of FIGS. 4A-4C delivered around a wound. [Figure 4E] FIG. 5 illustrates multiple closure elements of FIGS. 4A-4D delivered around a wound. [Figure 4F] FIG. 4C shows the closure element of FIGS. 4A-4E in an activated configuration. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] It should be noted that the drawings are intended to depict only typical or exemplary embodiments of the invention. Therefore, the drawings should not be considered as limiting the scope of the invention. In the following, the invention will be described in more detail with reference to the accompanying drawings.

[0012] Various embodiments of the present invention are described below: As used herein, "proximal end" refers to the end of a device along the device that is closest to a medical professional when the device is introduced into a patient's body, and "distal end" refers to the end of a device or object along the device that is furthest from a medical professional during implantation, positioning, or delivery.

[0013] As used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. As used in this specification and the appended claims, the term "or" is generally used in its sense to include "and / or" unless the context clearly dictates otherwise.

[0014] It should be noted that references herein to "embodiments," "some embodiments," "other embodiments," etc., indicate that the described embodiments may include one or more particular features, structures, and / or characteristics. However, such recitation does not necessarily imply that all embodiments include the particular feature, structure, and / or characteristic. Additionally, if a particular feature, structure, and / or characteristic is described in connection with one embodiment, it should be understood that such feature, structure, and / or characteristic may also be used in connection with other embodiments, whether or not explicitly described, unless expressly stated otherwise.

[0015] The detailed description should be read with reference to the drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. Many medical procedures, including endovascular procedures, procedures along the digestive, urinary, respiratory, reproductive and / or bile ducts, thoracic procedures, etc., utilize medical devices to access tissues (e.g., "target tissues") intended for removal within the body. For example, in some current medical procedures (EMR and ESD), a physician may utilize an endoscope, colonoscope, duodenoscope, bronchoscope, gastroscope, or similar medical device to access and remove diseased lesions, creating wounds or defects in the tissue. As used herein, a "wound" may include a defect, injury, bleeding, ulcer, luminal opening, or similar anatomical structure that a medical professional would like to close for sealing, healing, hemostasis, ligation, etc. In some instances, an endoscope may incorporate features that aid a physician in visualizing and performing a wound closure procedure. For example, some endoscopes may include lights and / or cameras designed to illuminate and / or visualize a body lumen as the endoscope is navigated and positioned adjacent to a target tissue site. Additionally, some endoscopes may also include lumens (e.g., working channels) through which resection devices, grasping members, or other accessory devices may be deployed and utilized therethrough. Additional visualization and / or external and / or internal imaging methods, such as fluoroscopy, may alternatively or additionally be employed.

[0016] In medical procedures, such as EMR and ESD, a portion of tissue, such as a body lumen or organ tissue, such as a mucosal layer, may be resected or ablated, resulting in a wound or defect in the tissue. In this regard, wound closure and healing may be assisted by one or more devices that substantially approximate the wound tissue (e.g., wound edges) so that the tissue layers are drawn together or approximated across the wound, for the purposes of, among other things, promoting tissue adhesion and ultimately wound healing, achieving hemostasis, etc. Another consideration is wounds that are larger than the direct working area of ​​the endoscope, e.g., wounds larger than about 2 cm in diameter, which may be difficult to close using devices sized to extend through the working channel of the endoscope. For these larger wounds, different configurations of closure devices and / or multiple closure devices may also be effective.

[0017] The devices, systems, and methods of the present invention may be used alone or in conjunction with other devices, systems, and methods to treat wounds. Exemplary devices, systems, and methods in which embodiments of the present invention may be implemented include, but are not limited to, those described in U.S. Patent Application No. 13 / 325,638, entitled "Endoscopic Device with Integrated Varicose Vein Ligation Device," filed December 14, 2011, which is incorporated herein by reference in its entirety for all purposes. The exemplary devices described therein may be modified to incorporate embodiments or one or more features of the present invention.

[0018] Referring to FIG. 1A, a device, e.g., a distal end of an endoscope 122 for closing a wound 130 according to one embodiment of the present invention is shown, which includes a closure element 100 having a shape memory configuration. The shape memory configuration of the closure element 100 can be a helical coil when deployed, although other shapes are contemplated as described herein. The coil is wider in the delivery configuration than in the deployed configuration. The pitch of the coil is straight along the longitudinal axis of the closure element 100, but the coil can be pitched a number of degrees that can vary between the delivery and deployed configurations. For example, the pitch of the coil in the deployed configuration can be such that the helix is ​​angled between about 0.01° and about 30°. The closure element 100 is delivered disposed around an end cap 120 of the endoscope 122. The end cap 120 is an elongated hollow tube that can be attached to the distal end of the endoscope 122 so that any working channel, imaging device, and / or illumination device remain unobstructed when the end cap 120 is attached to the endoscope 122. The diameter of the coil in the relaxed deployed configuration is smaller than the diameter of the outer surface of the end cap 120 such that the closure element 100 contracts around the end cap 120 in the delivery configuration. The end cap 120 positions the closure element 100 distal to an imaging device, e.g., a camera, of the endoscope 122 for a medical professional to visualize the closure element 100 and surrounding anatomical structures. The end cap 120 is substantially translucent to allow a medical professional to see through the end cap 120 to the closure element and surrounding anatomical structures. The closure element 100 is shown in a delivery configuration around the end cap 120, with the shape memory spring force of the closure element 100 constrained by the diameter of the shaft of the endoscope 122 (or by the shaft of another delivery device, catheter, elongate member, etc.) such that the closure element 100 is stretched to a diameter wide enough to fit around the end cap 120. The closure element 100 may be inserted into a body lumen of a patient in the delivery configuration around the end cap 120. The detachment filament 102 has a distal end 102d that is releasably coupled to the closure element 100 and a proximal end that extends within the end cap 120.The proximal end of the detachment filament 102 may extend through the endoscope 122 and terminate outside the proximal end of the endoscope 122. The proximal end of the detachment filament 102 may terminate in a handle or another device for actuation inside or outside the endoscope 122. The distal end 102d of the detachment filament 102 is a loop, although the distal end 102d may additionally or alternatively be other attachment mechanisms such as welding, adhesive, hooks, etc. The loop of the detachment filament may extend around more than one coil of the closure element 100 and extend the entire length of the closure element 100. The assembly of the closure element 100, detachment filament 102, and end cap 120 shown in FIG. 1A may be preloaded into the endoscope 122 prior to insertion into the patient's body. The end cap 120 may be oriented toward the wound 130 of the tissue 132, and the medical professional may move or navigate the endoscope 122 within the patient's body.

[0019] 1B, the end cap 120 of the endoscope 122 is positioned around the wound 130 to create a substantial seal between the distal end of the end cap 120 and the tissue 132 surrounding the wound 130. The area within the end cap 120 may be aspirated via a suction and / or vacuum source in communication with an aspiration channel of the endoscope 122. The suction force may create a negative pressure within the end cap 120, which displaces at least a portion of the wound 130 and surrounding tissue 132 proximally into the end cap 120. With the wound 130 at least partially displaced into the end cap 120, the distal end 102d of the detachment filament 102 extends outwardly of the distal end of the end cap 120 and is maintained extended proximally along the outside of the end cap 120 to a site where the loop is coupled to the closure element 100 (disposed around the outside of the end cap 120 in the delivery configuration).

[0020] 1C , with the wound 130 and surrounding tissue 132 at least partially displaced proximally within the end cap 120, the detachment filament 102 can be moved (e.g., pulled) proximally to begin transitioning the closure element 100 from a delivery configuration about the end cap 120 to a deployed configuration about the wound 130. In FIG. 1C , as the detachment filament 102 is moved proximally into the end cap 120, the distal end 102d of the detachment filament 102 displaces the distal end 100d of the closure element 100 from the distal end of the end cap 120 and displaces it about the wound 130. The suction force displacing the tissue 132 keeps the tissue 132 in tension, allowing the coils of the closure element 100 to contract around the edges of the wound 130. The delivered closure element 100 has an inward closure force while the tissue 132 has an opposing relaxation force on the closure element 100 resulting in a snug fit. The distal end 102d of the detachment filament 102 is detached (e.g., slipped off, separated, etc.) from the closure element 100 as the detachment filament 102 is moved proximally into the end cap 120. The distal end 102d of the detachment filament 102 is separated from the end of the closure element 100 before the closure element 100 engages the tissue 132 or after the closure element 100 engages the tissue 132, e.g., the distal end 102d of the detachment filament 102 slips off the closure element 100 by temporarily uncoupling a portion of the closure element 100 from the tissue 132 and then re-engages the tissue 132 due to the inward closure force of the closure element 100. When portions (e.g., the coil windings) of the closure element 100 (e.g., the distal end 100d) are disengaged from the end cap 120 around the wound 130, those portions of the closure element 100 transition from a stressed delivery configuration having a larger diameter to an unstressed deployed configuration having a smaller diameter. The deployed configuration of the distal end 100d of the closure element 100 contracts around the wound 130 and surrounding tissue 132 due to the shape memory configuration of the closure element 100.The deployed portion of the closure element, which contracts the tissue 132, secures the distal end 100d of the closure element 100, such that as the remaining portion of the closure element 100 is disengaged from the end cap 120 and engaged around the wound 130, the endoscope 122 is moved proximally and the end cap 120 is pulled proximally away from the distal end 100d.

[0021] Referring to FIG. 1D, the closure element 100 is shown in a deployed configuration around the wound 130 and surrounding tissue 132. The closure element 100 is not in a completely relaxed, stress-free state because the tissue 132 provides some resistance to the closure element 100 contracting the tissue 132. The closure element 100 in the deployed configuration may result in an approximately cone shape with an apex on the wound 130 away from the tissue 132. This shape results in a smaller volume of tissue 132 within the closure element 100 at the site of the wound 130 compared to the larger amount of tissue 132 within the closure element 100 away from the site of the wound 130 and / or the volume of tissue 132 displaced into the end cap 120. Alternatively, the closure element 100 may have an approximately cylindrical or inverted cone shape (i.e., compared to the cone shape of FIG. 1D), in which case a larger amount of tissue 132 is displaced such that more tissue is displaced than shown in FIG. 1D. For example, a portion of tissue 132 may extend proximally from closure device 100, forming a bulbous or mushroom shape. The exposed area of ​​wound 130 is smaller and the edges of wound 130 are closer together in Figure 1C than the larger area and flared edges of wound 130 in Figure 1A. Because the diameter of the coil of closure element 100 in the deployed configuration may decrease, the radial closure force toward the longitudinal axis of closure element 100 may increase.

[0022] 2A and 2B, an apparatus for closing a wound 230 is shown in accordance with an embodiment of the present invention, which includes a closure element 200 having a shape memory configuration. The shape memory configuration of the closure element 200 is shown as a knot, although other shapes are contemplated as described herein. The closure element 200 includes a protrusion 200d at each end of the closure element 200 that is configured to penetrate tissue or to embed and engage tissue. The illustrated protrusions 200d are arrowhead-shaped barbs, but the protrusions 200d may be hooks, tines, and the like. The closure element 200 is disposed about an end cap 220 of an endoscope 222. The closure element 200 is shown in a delivery configuration around the end cap 220, where the shape memory spring force of the closure element 200 expands and stresses the closure element 200 to a diameter wide enough to fit around the end cap 220. The delivery configuration of the closure element 200 is shown in FIG. 2B. The closure element 200 may be inserted into a patient's body lumen in a delivery configuration around the end cap 220. The detachment filament 202 has a distal end 202d releasably coupled to the closure element 200 and a proximal end extending within the end cap 220. The distal end 202d of the detachment filament 202 is a loop, although the distal end 202d may additionally or alternatively be other releasable coupling mechanisms such as spot welds, adhesives, hooks, etc. The assembly of the closure element 200, detachment filament 202, and end cap 220 shown in FIG. 2A may be preloaded into an endoscope 222 prior to insertion into a patient's body. The end cap 220 may be oriented to a wound 230 in tissue 232.

[0023] 2C, the end cap 220 of the endoscope 222 is positioned about the wound 230 to form a seal between the distal end of the end cap 220 and the tissue 232 surrounding the wound 230. The area within the end cap 220 may be aspirated via a suction and / or vacuum source in communication with the suction channel of the endoscope 222. The suction force creates a negative pressure within the end cap 220. This displaces at least a portion of the wound 230 and surrounding tissue 232 proximally into the end cap 220. With the wound 230 displaced into the end cap 220, the release filament 202 is moved proximally to transition the closure element 200 from a delivery configuration about the end cap 220 to a deployed configuration about the wound 230. 2C , as the detachment filament 202 is moved proximally into the end cap 220, the distal end 202d of the detachment filament 202 displaces the closure element 200 out of the end cap 220 and around the wound 230. The distal end 202d of the detachment filament 202 is detached (e.g., slipped off, separated, detached, etc.) from the closure element 200 as the detachment filament 202 is moved proximally into the end cap 220. The distal end 202d of the detachment filament 202 detaches from the end of the closure element 200 either before the closure element 200 engages the tissue 232 or after the closure element 200 engages the tissue 232, e.g., the distal end 202d of the detachment filament 202 slips off the closure element 200 by temporarily uncoupling a portion of the closure element 200 from the tissue 232 and then re-engages the tissue 232 due to the inward closure force of the closure element 200. The detachment filament may be separated from the closure element 200 by disengaging from the prongs 200d. As the closure element 200 disengages from the end caps 220 and displaces about the wound 230, the closure element 200 transitions from an expanded delivery configuration having a larger diameter to an unexpanded deployed configuration having a smaller diameter.

[0024] 2D and 2E, the deployed configuration of the closure element 200 contracts around the wound 230 and surrounding tissue 232 due to the shape memory of the closure element 200. The deployed configuration of the closure element 200 is shown in FIG. 2E. In the deployed configuration, the closure element transitions to an unstressed knotted shape memory orientation (e.g., knotted, pretzel-like, etc.) and the projections 200d are oriented inwardly of the closure element 200d such that a portion of the length of the closure element 200 overlaps itself. The projections 200d may be fully embedded, partially embedded, or not embedded in the tissue 232.

[0025] 3A and 3B, a device for closing a wound 330 according to one embodiment of the present disclosure is shown, which includes a plurality of closure elements 300 arranged around an end cap 320 in a delivery configuration. Each of the closure elements 300 includes a protrusion 300d at each end of the closure element 300 configured to penetrate or embed and engage tissue. The protrusions 300d are barbs, although the protrusions 300d can be hooks, tines, etc. The device includes a detachment filament 302 having a distal portion that is coupled to each of the closure elements 300 by a series of loops 302d. The detachment filaments described elsewhere in this disclosure can be used in a manner generally similar to the detachment filament 302 shown in FIG. 3A and 3B (e.g., a detachment filament 102 or one or more detachment filaments 202 with a loop around each winding of the detachment filament 102). Each loop 302d of the detachment filament 302 extends independently around each of the closure elements 300 while the closure elements 300 are in a delivery configuration. The detachment filament 302 has a proximal portion 302p that extends into the end cap 320. Proximal movement of the proximal portion 302p of the detachment filament 302 transfers a pulling force to the distal-most loop 302d-1 as the detachment filament 302 extends from inside the end cap 320 to outside the end cap by extending beyond the distal end 320d of the end cap 320. The distal end 320d of the end cap 320 can be oriented toward, around, and / or in contact with the wound 330 and / or surrounding tissue 332. As shown in FIG. 3B, suction can be introduced in communication with the end cap 320 to displace the wound 330 into the end cap 320. The detachment filament 302 can be moved proximally such that the distal-most loop 300d pulls the respective closure element 300 distally along the outside of the end cap 320. The detachment filament 302 is continuously moved proximally such that the distal-most closure element 300 is displaced out of the end cap 320 and transitions from the delivery configuration to the deployed configuration. As shown in FIG. 3B, the closure element 300-1 is deployed into tissue 332.Proximal movement of the proximal portion 302p of the release filament 302 displaces the distal-most loop 302d-2 along with the closure element 300-2 in a distal direction along the end cap 320. As the closure element 300-2 is displaced off the distal end 320d of the end cap 320, the closure element 300-2 begins to transition from a delivery configuration to a deployed configuration and the loop 302d-2 begins to disengage from the closure element 300-2. After deployment of the closure element 300-2, the distal-most closure element 300-3 can be deployed at the same tissue 332 site or at a different tissue site by moving the proximal portion 302p proximally such that the distal-most loop 302d-3 can be displaced.

[0026] 4A and 4B, a device according to one embodiment of the present disclosure is shown including a closure element 400. The closure element 400 has an elongated non-activated configuration shown in FIG. 4A and a curved activated configuration shown in FIG. 4B. In the non-activated configuration, the closure element 400 extends in a generally straight line from one end 400d of the closure element 400 to the other end 400d. In the activated configuration, the ends 400d of the closure element 400 curl toward each other. Although the activated configuration of the closure element 400 is shown as being substantially "C-shaped," the activated configuration can be of various shapes, such as, for example, "U-shaped," "S-shaped," "Z-shaped," or combinations thereof. The closure element 400 includes a plurality of activatable portions 402 along the length of the closure element 400. Although four activatable portions 402 are shown, any number of activatable portions 402 may be utilized, e.g., 1, 2, 3, 5, 8, 10, 20, 100, 1000, etc. Additionally or alternatively, the activatable portions 402 may be blended to mix within other portions of the closure element 400. The blended portions may include a generally uniform mixture throughout the blend, or the blend may have various percentages of each portion that increase or decrease along the length of the closure element 400. The activatable portions 402 may be sensitive to activation from an external stimulus source, such as heat, light, infrared light, electricity, energy, pH, etc., that may cause the activatable portions 402 to change the geometry of the closure element 400. The activatable portions 402 may be patterned along the closure element 400 at specific locations to act as actuating hinges or folding points where the shape of the closure element 400 can change into an activated (e.g., curved) configuration. Each activatable portion 402 may contract a number of degrees d (e.g., from about 0° to about 360°) such that the closure element 400 in the activated configuration has an overall curvature α equal to the number of activatable portions 402 multiplied by the number of degrees d. The closure element 400 (or other closure elements described herein) may also include biodegradable portions 404 along the length of the closure element 400. The closure element 400 may include only activatable portions, only biodegradable portions, or neither. The portions may be located at different locations along the length of the closure element 400 and may have arrangements other than those shown in the figures.For example, one or more projections of the closure element can be non-biodegradable and the remainder of the closure element can be biodegradable, such that one or more projections remain within the tissue while the remainder of the closure element passes. The biodegradable portion 404 can degrade over time after deployment within a patient, and once the wound corresponding to the closure element 400 has healed and the closure element 400 is no longer needed (e.g., within about 7 days, within about 14 days, within about one month, within about several months, within about one year, etc., depending on the material used and the characteristics of the wound), the biodegradable portion 404 can degrade sufficiently such that the closure element 400 falls off the tissue. Although three biodegradable portions 404 are shown, any number of biodegradable portions 404 can be utilized, e.g., 1, 2, 4, 5, 8, 10, 20, 100, 1000, etc. Additionally or alternatively, the biodegradable portion 404 can be blended to mix within other portions of the closure filament 400. The biodegradable portion 404 or other portions may include drugs (e.g., pain relieving, healing, antibacterial, etc.) that may aid in wound healing or otherwise be released into the patient's body. Ends 400d each include a prong configured to pierce tissue or to embed and engage tissue. The prongs are shown as sharp points, but may be barbs, hooks, tines, etc.

[0027] 4C-4F, the closure element 400 of FIGS. 4A and 4B can be used to close a wound 430. As shown in FIG. 4C, the wound 430 and surrounding tissue 432 can be displaced via a medical instrument 422 (e.g., a grasper, a working channel with suction, a clip, etc.). A delivery device 420 (e.g., a needle, a catheter, etc.) having the closure element 400 in an elongated, unactivated configuration can be configured for tissue insertion and oriented to the wound 430 and tissue 432. As shown in FIG. 4D, the closure element 400 can be delivered across the wound 430 and into the tissue 432 by leading protrusions on the ends 400d of the closure element 400. The tissue 432 may be displaced (e.g., tissue edges are approximated) by the medical instrument 422 (e.g., forceps or grasper) to allow the end 400d of the closure element 400 to penetrate two sides of the tissue 432 around the wound 430 in one insertion motion along the longitudinal axis of the closure element 400. Additional closure elements 400 may be delivered from the delivery device 420 such that multiple closure elements 400 are delivered across the wound 430 and into the tissue 432 as shown in FIG. 4E (where the tissue 432 has been detached from the medical instrument 422). Although four closure elements 400 are shown in FIG. 4E, any number of closure elements 400 may be used, e.g., 1, 2, 3, 5, 8, 10, 20, 100, etc., such that the closure elements 400 extend across a substantial area of ​​the wound 430. The closure elements 400 are shown in an unactivated configuration in FIG. 4E after delivery. An activator external to the closure elements 400 may activate the activatable portions 402 of each closure element 400 such that they transition from a non-activated configuration to an activated configuration. The activated configuration of the closure elements 400 across the wound 430 is shown in FIG. 4F. The activatable portions 402 are contracted such that the ends 400d curl toward each other, and the wound 430 is substantially closed or closed such that the edges of the wound 430 are closer together than in FIG. 4E. Over time, the biodegradable portions 404 may degrade such that the closure members 400 move away from the tissue 432. Alternatively, no portion of the closure members 400 may degrade, and the closure members 400 may move away from the tissue 432 as the wound 430 heals, scabs, scars, and / or falls off.

[0028] In various embodiments, a medical professional may attach an end cap to an endoscope, catheter, or the like. The medical professional may load one or more closure elements onto the end cap. The one or more closure elements may be releasably coupled to a detachment filament extending through the end cap and attached to a handle. The endoscope and assembly may be inserted into a patient. A target wound may be positioned. The end cap may be oriented to the wound. The wound or surrounding tissue may be displaced into the end cap. The one or more closure elements may be detached around the wound by the medical professional manipulating the detachment filament.

[0029] In various embodiments, a medical professional may insert one or more non-activated closure elements into a delivery device, such as a needle. The delivery device may be inserted into a patient's body. A target wound may be positioned. The delivery device may be oriented to the wound. The one or more closure elements may be deployed into tissue around the wound. The one or more closure elements may be activated such that the one or more closure elements transition from a non-activated configuration to an activated configuration.

[0030] In various embodiments, the closure element may include a shape memory material such as Nitinol, stainless steel, nickel titanium, alloys, polymers, rubber, nylon, combinations thereof, etc. The closure element may have a shape and shape memory set by a mandrel or a shape or shape memory. The shape of the closure element may include coil, spiral, knot, pretzel, straight line, "C-shaped," "V-shaped," "U-shaped," "S-shaped," "Z-shaped," combinations thereof, etc. The closure element may be heat set to a diameter (e.g., about 1 mm to about 5 mm diameter, etc.) that may be selectable based on the wound geometry and size.

[0031] In various embodiments, the end caps described and illustrated herein may be coupled (e.g., insertable, adhered, integrally manufactured, etc.) to an endoscope, a catheter, and / or a working channel. The end cap may additionally or alternatively be an extension of the endoscope, a catheter, and / or a working channel.

[0032] Devices according to the described embodiments, as well as devices according to other embodiments of the present disclosure, may be used alone or in a system or kit, including other accessories, or as part of a method or procedure in body cavities, lumens, ducts, vessels and organs, such as to access, treat or diagnose conditions in the peritoneal, abdominal, bronchial or thoracic cavities, blood vessels, gastrointestinal or urinary tract, uterus, bladder, lung and liver organs, etc.

[0033] In addition to the various embodiments described herein, variations, modifications, and other implementations of the disclosure will occur to those skilled in the art. Accordingly, the invention is to be defined by the following claims rather than the foregoing illustrative description.

Claims

1. a closure element having a delivery configuration and a deployment configuration, the closure element being configured to be disposed about an end cap of an endoscope in the delivery configuration; a detachment filament having a distal end releasably coupled to the closure element and a proximal end extending into the end cap; Equipped with A device for closing a wound, wherein the closure element is configured to close about a wound in the deployed configuration.

2. The device of claim 1 , further comprising a plurality of the closure elements in the delivery configuration about the endoscope end, each separately and releasably coupled to the detachment filament.

3. The device of claim 1 or 2, wherein the deployed configuration of the closure element is a shape-memory configuration.

4. The device of claim 3 , wherein the shape memory configuration of the closure element is a coil, a knot, a torus, or a combination thereof.

5. 5. The device of claim 1, wherein the closure element extends along a length between its ends and further comprises tissue piercing protrusions at each end of the closure element, the tissue piercing protrusions being hooks, tines, barbs, or combinations thereof.

6. The device of claim 3 , wherein the shape memory configuration of the closure element is activated by a stimulus, the stimulus comprising light activation, heat activation, or electrical activation, or a combination thereof.

7. The device of any one of claims 1 to 6, wherein the distal end of the detachment filament comprises a loop.

8. The device of claim 7 , wherein the loop is disposed around a coil of the closure element.

9. The device of claim 7 , wherein the loop is disposed about a length of the closure element.

10. The device of any one of claims 1 to 9, wherein the detachment filament has a tensile strength greater than a tensile strength of the closure element.

11. Closure element having an elongated non-activated configuration and an activated configuration - Patents.com Equipped with the closure element in the elongate unactivated configuration is configured to be inserted into a tissue edge facing a wound; the closure element in the activated configuration is configured to approximate the tissue edges to close at least a portion of the wound. A device for closing wounds.

12. 10. The device of claim 9, wherein the closure element comprises a plurality of biodegradable portions interspersed between a plurality of adjacent light-activated shape memory portions along a length of the closure element.

13. The device of claim 12 , wherein the biodegradable portions are at least partially intermingled with adjacent light-activated shape memory portions along the length of the closure element.

14. The device of any one of claims 11 to 13, wherein the closure element comprises first and second ends configured to curl towards each other in the activated configuration.

15. The device of any one of claims 11 to 14, wherein the activated configuration of the closure element is a light-activated shape-memory configuration.

Images